This week, we are taking a closer look at Pepper Bio's seed pitch deck that landed the company $6.5 million.
To ensure survival, it’s essential to explore alternative funding methods rather than relying solely on classic fundraising.
It’s becoming clear that longevity as a theme has resonated with investors, though it appears it will be some time before more generalist investors take interest.
The company's three-pronged technology includes creating ideal environment for the shrimp, remote operations management and AI-powered automation to monitor and feed them.
Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics. “Lateral flow,” in this case, is the same
Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. It’s a sign that certain invest
Planetary aims to bring all of the alternative protein production planets into orbit with its scaling technology.
When the topic of fertility comes up, we often hear hushed tones discussing someone else’s or their own journey through infertility.
We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.
A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which it hopes can make therapies that traditionally requi
China is allowing the public to take COVID-19 rapid antigen self-tests for the first time as infection numbers hit a two-year high in recent days. Online marketplaces including JD.com and Meituan are
Cellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR advisor who threw the startup’s name in the ring as a
The company touts its Fine Mycelium process as the only mycelium engineered to be made-to-order and made-to-specification.
The success of CRISPR technology in agriculture has been well documented as a way to manipulate plant genomes to make them more pest and climate resistant and grow more consistent products.
Longevica's goal is to validate the pipeline of turning scientific research into consumer-ready products.
Adil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others, that cost could come down 10 times.
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines
The company has been busy strengthening its supply chain to gear up for scaling its product. Additionally, it hired a head of growth and a community engagement and success manager.
Cellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021’s Startup Battlefield to detail how its system, which combines AI technology
Human life expectancy increased from 31 years in 1900 to 72 years in 2017. Today, we are on the cusp of another healthcare revolution driven by artificial intelligence.